NCT00460928View on ClinicalTrials.gov

Preventive IVIG Therapy for Congenital Heart Block

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Congenital Heart BlockNeonatal LupusAutoantibody-associated Heart Block
Interventions
DRUG

intravenous immune globulin (IVIG)

Trial Locations (2)

10016

New York University School of Medicine / NYU-Hospital for Joint Diseases, New York

07039

Saint Barnabas Medical Center, Livingston

Sponsors

Collaborators (1)

Lupus Research Alliance
All Listed Sponsors
collaborator

Lupus Research Alliance

OTHER

lead

NYU Langone Health

OTHER